Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis.

van Hulsteijn LT, Dekkers OM, Hes FJ, Smit JW, Corssmit EP.

J Med Genet. 2012 Dec;49(12):768-76. doi: 10.1136/jmedgenet-2012-101192. Epub 2012 Oct 25. Review.

PMID:
23099648
2.

High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations.

Heesterman BL, Bayley JP, Tops CM, Hes FJ, van Brussel BT, Corssmit EP, Hamming JF, van der Mey AG, Jansen JC.

Eur J Hum Genet. 2013 Apr;21(4):469-70. doi: 10.1038/ejhg.2012.203. Epub 2012 Sep 5.

3.

Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.

Oishi Y, Nagai S, Yoshida M, Fujisawa S, Sazawa A, Shinohara N, Nonomura K, Matsuno K, Shimizu C.

Endocr J. 2010;57(8):745-50. Epub 2010 May 25.

4.

Mutations of the SDHB and SDHD genes.

Pawlu C, Bausch B, Neumann HP.

Fam Cancer. 2005;4(1):49-54. Review.

PMID:
15883710
5.

Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.

Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PL, Elston M, Gimm O, Henley D, Herman P, Murday V, Niccoli-Sire P, Pasieka JL, Rohmer V, Tucker K, Jeunemaitre X, Marsh DJ, Plouin PF, Robinson BG.

J Clin Endocrinol Metab. 2006 Mar;91(3):827-36. Epub 2005 Nov 29.

PMID:
16317055
6.

Malignant head and neck paragangliomas in SDHB mutation carriers.

Boedeker CC, Neumann HP, Maier W, Bausch B, Schipper J, Ridder GJ.

Otolaryngol Head Neck Surg. 2007 Jul;137(1):126-9.

PMID:
17599579
7.

Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.

Baysal BE, Willett-Brozick JE, Lawrence EC, Drovdlic CM, Savul SA, McLeod DR, Yee HA, Brackmann DE, Slattery WH 3rd, Myers EN, Ferrell RE, Rubinstein WS.

J Med Genet. 2002 Mar;39(3):178-83.

8.

High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.

Hensen EF, van Duinen N, Jansen JC, Corssmit EP, Tops CM, Romijn JA, Vriends AH, van der Mey AG, Cornelisse CJ, Devilee P, Bayley JP.

Clin Genet. 2012 Mar;81(3):284-8. doi: 10.1111/j.1399-0004.2011.01653.x. Epub 2011 Mar 15.

PMID:
21348866
9.

[Paragangliomas and paraganglioma syndromes].

Boedeker CC.

Laryngorhinootologie. 2011 Mar;90 Suppl 1:S56-82. doi: 10.1055/s-0030-1270447. Epub 2011 Apr 26. Review. German.

PMID:
21523634
10.

Mutations associated with succinate dehydrogenase D-related malignant paragangliomas.

Timmers HJ, Pacak K, Bertherat J, Lenders JW, Duet M, Eisenhofer G, Stratakis CA, Niccoli-Sire P, Tran BH, Burnichon N, Gimenez-Roqueplo AP.

Clin Endocrinol (Oxf). 2008 Apr;68(4):561-6. Epub 2007 Oct 31.

PMID:
17973943
11.

High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.

Persu A, Hamoir M, Grégoire V, Garin P, Duvivier E, Reychler H, Chantrain G, Mortier G, Mourad M, Maiter D, Vikkula M.

J Hypertens. 2008 Jul;26(7):1395-401. doi: 10.1097/HJH.0b013e3282ffdc54.

PMID:
18551016
12.

Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.

Astuti D, Hart-Holden N, Latif F, Lalloo F, Black GC, Lim C, Moran A, Grossman AB, Hodgson SV, Freemont A, Ramsden R, Eng C, Evans DG, Maher ER.

Clin Endocrinol (Oxf). 2003 Dec;59(6):728-33.

PMID:
14974914
13.

R46Q mutation in the succinate dehydrogenase B gene (SDHB) in a Japanese family with both abdominal and thoracic paraganglioma following metastasis.

Takekoshi K, Isobe K, Suzuki H, Nissato S, Kawakami Y, Kawai K, Yamada N.

Endocr J. 2008 May;55(2):299-303. Epub 2008 Mar 25.

14.

SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas.

Mhatre AN, Li Y, Feng L, Gasperin A, Lalwani AK.

Clin Genet. 2004 Nov;66(5):461-6.

PMID:
15479192
15.

Genomic imprinting and environment in hereditary paraganglioma.

Baysal BE.

Am J Med Genet C Semin Med Genet. 2004 Aug 15;129C(1):85-90. Review.

PMID:
15264276
16.

Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion.

Rijken JA, Niemeijer ND, Corssmit EP, Jonker MA, Leemans CR, Menko FH, Hensen EF.

Clin Genet. 2016 Jan;89(1):128-32. doi: 10.1111/cge.12591. Epub 2015 Apr 27.

PMID:
25827221
17.

Phenotype of SDHB mutation carriers in the Netherlands.

van Hulsteijn LT, Niemeijer ND, Hes FJ, Bayley JP, Tops CM, Jansen JC, Corssmit EP.

Fam Cancer. 2014 Dec;13(4):651-7. doi: 10.1007/s10689-014-9738-z.

PMID:
25047027
18.

Clinical features of paraganglioma syndromes.

Boedeker CC, Neumann HP, Offergeld C, Maier W, Falcioni M, Berlis A, Schipper J.

Skull Base. 2009 Jan;19(1):17-25. doi: 10.1055/s-0028-1103123.

19.

No difference in phenotype of the main Dutch SDHD founder mutations.

van Hulsteijn LT, den Dulk AC, Hes FJ, Bayley JP, Jansen JC, Corssmit EP.

Clin Endocrinol (Oxf). 2013 Dec;79(6):824-31. doi: 10.1111/cen.12223. Epub 2013 May 11.

PMID:
23586964
20.

Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.

Gill AJ, Benn DE, Chou A, Clarkson A, Muljono A, Meyer-Rochow GY, Richardson AL, Sidhu SB, Robinson BG, Clifton-Bligh RJ.

Hum Pathol. 2010 Jun;41(6):805-14. doi: 10.1016/j.humpath.2009.12.005. Epub 2010 Mar 17.

PMID:
20236688

Supplemental Content

Support Center